Barclays »

Crescent Biopharma shares owned by Barclays

Quarter-by-quarter ownership of Crescent Biopharma (CBIO) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Crescent Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Crescent Biopharma held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crescent Biopharma by Barclays

Quarter filed Position value Share count Share price at filing
2026-03-31 $555k 30k 18.37
2025-06-30 $3.8k 286 13.16

More positions owned by Barclays

Ishares Tr Opt Put Option (EEM)
Microsoft Corporation (MSFT)
STATE STR SPDR S&ampP 500 ETF T Opt Call Option (SPY)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Opt Call Option (QQQ)
Ishares Tr Fund (IWM)
Apple (AAPL)
Amazon (AMZN)
Alphabet Inc Class A cs (GOOGL)
Facebook Inc cl a (META)
Broadcom (AVGO)
Tesla Motors (TSLA)
Ishares Tr Opt Put Option (HYG)
JPMORGAN CHASE &amp Opt Call Option (JPM)
Alphabet Inc Class C cs (GOOG)

View all positions for Barclays

Top funds holding Crescent Biopharma

FMR
BVF
Fairmount Funds Management
VR Adviser
Fcpm Iii Services B.v.
Balyasny Asset Management
Vestal Point Capital
Opaleye Management
Tang Capital Management
Vanguard Capital Management
Logos Global Management
Deep Track Capital
Rtw Investments
Millennium Management
Point72 Asset Management

View all funds holding Crescent Biopharma